InspireMD Newsroom

Press Release: InspireMD Announces Appointment of Accomplished Medical Technology Executive Scott R. Ward to Its Board of Directors

Dow JonesNov 25 16:05 ET

Express News | InspireMD Announces Appointment of Accomplished Medical Technology Executive Scott R. Ward to Its Board of Directors

ReutersNov 25 16:05 ET

InspireMD Third Quarter 2024 Earnings: US$0.16 Loss per Share (Vs US$0.15 Loss in 3Q 2023)

Yahoo FinanceNov 14 05:17 ET

Express News | InspireMD Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Financial Results

BenzingaNov 13 13:16 ET

InspireMD Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Financial Results.

BenzingaNov 13 13:16 ET

InspireMD Inc. Faces Financial Uncertainty Amidst Ongoing Losses and Cash Flow Challenges

TipRanksNov 13 01:01 ET

InspireMD | 10-Q: Q3 2024 Earnings Report

SECNov 12 12:00 ET · Announcements

InspireMD Achieves Record Q3 Revenue With CGuard Success

TipRanksNov 12 11:16 ET

InspireMD, Inc. (NSPR) Q3 2024 Earnings Call Transcript Summary

moomoo AINov 12 10:24 ET · Conference Call

InspireMD, Inc. (NSPR) Reports Q3 Loss, Tops Revenue Estimates

Zacks Nov 12 07:35 ET

Express News | InspireMD Q3 Operating Expenses USD 8.876 Million

ReutersNov 12 07:00 ET

Express News | InspireMD Q3 Gross Profit USD 414 Thousand

ReutersNov 12 07:00 ET

Express News | InspireMD Q3 Basic EPS USD -0.16

ReutersNov 12 07:00 ET

InspireMD 3Q Rev $1.81M >NSPR

Dow JonesNov 12 07:00 ET

Press Release: InspireMD Reports Third Quarter 2024 Financial Results and Provides Business Update

Dow JonesNov 12 07:00 ET

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswireNov 8 17:30 ET

Express News | InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

ReutersNov 8 17:30 ET

Press Release: InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Dow JonesNov 8 17:30 ET

InspireMD (NSPR.US) will release its financial report before the market opens on November 12th.

$InspireMD(NSPR.US)$ will release its financial report before the market opens on November 12th. How was the previous performance? $InspireMD(NSPR.US)$ revenue in 2024/Q2 was $1.739 million, net income was -$-7.909 million, and EPS was -$0.22. Revenue in 2023/Q3 was $1.556 million, net income was -$-5.178 million, and EPS was -$0.15. The above data is based on US_GAAP accounting standards. Reminder: 1. Listed on the Hong Kong and U.S. stock markets

Moomoo NewsNov 6 20:00 ET

Express News | InspireMD to Report Third Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, November 12TH

ReutersNov 4 08:00 ET